http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1480025-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68 |
| filingDate | 1975-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1480025-A |
| titleOfInvention | Derivatives of pyrazolo-(4,3-c)pyridimes |
| abstract | 1480025 Pyrazolo[4,3-c]pyridine derivatives E R SQUIBB & SONS Inc 15 May 1975 [22 July 1974] 20693/75 Heading C2C The invention comprises compounds of formula and their N-oxides and pharmaceutically acceptable acid addition salts, wherein each R is independently thienyl, pyridyl or XC 6 H 4 ; X is H, Cl, F, CF 3 or C 1-4 alkyl or alkoxy; and R<SP>1</SP>, R<SP>2</SP> are each H, C 1-4 alkyl (possibly substituted by OH or XC 6 H 4 ) or C 1-4 alkanoyl. In examples 3,5-di-(arylmethylene)-1-R<SP>1</SP>-piperid- 4-ones are reacted with R<SP>2</SP>NHNH 2 and the resulting 7 - arylmethylene analogues of (I) are hydrogenated to give the desired products which may be converted to N-oxides or salts, or (when R<SP>1</SP> or R<SP>2</SP>=H) may be acylated. Therapeutic compositions having antiinflammatory activity comprise compounds of the above formula and may be administered orally or parenterally. |
| priorityDate | 1974-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426241070 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19930500 |
Total number of triples: 14.